HI
TEVA icon

Harbour Investments’s Teva Pharmaceuticals TEVA Stock Holding History

Harbour Investments’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$52.5K Sell
1,551
-2
-0.1% -$67 ﹤0.01% 2374
2026
Q1 		$46.8K Buy
1,553
+475
+44% +$15.3K ﹤0.01% 2375
2025
Q4 		$33.6K Buy
1,078
+100
+10% +$2.46K ﹤0.01% 2152
2025
Q3 		$19.8K Hold
978
– – ﹤0.01% 2344
2025
Q2 		$16.4K Buy
978
+366
+60% +$5.91K ﹤0.01% 2331
2025
Q1 		$9.41K Sell
612
-107
-15% -$1.91K ﹤0.01% 2553
2024
Q4 		$15.8K Hold
719
– – ﹤0.01% 2233
2024
Q3 		$13K Buy
719
+57
+9% +$998 ﹤0.01% 2243
2024
Q2 		$10.8K Sell
662
-225
-25% -$3.47K ﹤0.01% 2227
2024
Q1 		$12.5K Hold
887
– – ﹤0.01% 2140
2023
Q4 		$9.26K Buy
887
+168
+23% +$1.57K ﹤0.01% 2166
2023
Q3 		$7.33K Buy
719
+17
+2% +$158 ﹤0.01% 2152
2023
Q2 		$5.29K Buy
702
+60
+9% +$487 ﹤0.01% 2266
2023
Q1 		$5.68K Sell
642
-20
-3% -$198 ﹤0.01% 2227
2022
Q4 		$6.04K Hold
662
– – ﹤0.01% 2160
2022
Q3 		$5K Hold
662
– – ﹤0.01% 2204
2022
Q2 		$5K Buy
+662
New +$5.77K ﹤0.01% 2204
2021
Q4 		$5K Sell
612
-95
-13% -$857 ﹤0.01% 2198
2021
Q3 		$7K Buy
707
+65
+10% +$609 ﹤0.01% 2854
2021
Q2 		$6K Buy
642
+100
+18% +$1.06K ﹤0.01% 2991
2021
Q1 		$6K Buy
+542
New +$6.21K ﹤0.01% 2857

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Harbour Investments's TEVA Position: Q2 2026 in Review

Harbour Investments reduced its Teva Pharmaceuticals (TEVA) stake by 0.13% in Q2 2026, selling an estimated $67 and leaving 1,551 shares worth $52.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2374.

Harbour Investments first reported a position in TEVA in Q1 2021 and has held it in 21 quarters since. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Harbour Investments held 1,551 shares of Teva Pharmaceuticals worth $52.5K as of Q2 2026.
  • Harbour Investments sold 2 Teva Pharmaceuticals shares in Q2 2026, an estimated $67.
  • Teva Pharmaceuticals made up ﹤0.01% of Harbour Investments's portfolio in Q2 2026, its #2374 holding.
  • Harbour Investments first reported a position in Teva Pharmaceuticals in Q1 2021 and has held it in 21 quarters since.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Harbour Investments's 13F filing for Q2 2026, filed 12 Aug 2026.